![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Detectable Resistance to Tenofovir Disoproxil Fumarate (TDF) in HBeAg+ and HBeAg- Patients With Chronic Hepatitis B (CHB) After Eight Years of Treatment
|
|
|
Reported by Jules Levin
APASL 2015
March 12-15, Istanbul, Turkey
Amoreena Corsa,1 Yang Liu,1 John Flaherty,1 Patrick Marcellin,2 Michael Miller,1 Kathryn M. Kitrinos1
1Gilead Sciences, Inc., Foster City, California, USA; 2Hopital Beaujon, University of Paris, Clichy, France
![CROI1.gif](../images/032715/032715-4/CROI1.gif)
![CROI2.gif](../images/032715/032715-4/CROI2.gif)
![CROI3.gif](../images/032715/032715-4/CROI3.gif)
![CROI4.gif](../images/032715/032715-4/CROI4.gif)
![CROI5.gif](../images/032715/032715-4/CROI5.gif)
![CROI6.gif](../images/032715/032715-4/CROI6.gif)
![CROI7.gif](../images/032715/032715-4/CROI7.gif)
![CROI8.gif](../images/032715/032715-4/CROI8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|